Summary
Determining safe and effective antiarrhythmic therapy in paediatric patients requires definition of the mechanism of the arrhythmia, determination of associated risk factors for treatment (such as the presence of congenital cardiac defects, myocarditis or cardiomyopathy), and monitoring for potential drug side effects related to the treatment. A number of modalities for non-invasive evaluation of arrhythmias is available, including ECG, 24-hour ambulatory Holter monitoring, and transtelephonic ECG transmission. Arrhythmias requiring medical treatment in children with normal cardiac anatomy and function include suprayentricular tachycardia (SVT), ventricular tachycardia (VT) and primary atrial tachycardias. SVT is treated acutely with vagai manoeuvres or drugs which slow AV conduction [adenosine (adenine riboside), edrophonium, phenylephrine or verapamil]. When medical conversion is not achieved, transoesophageal overdrive pacing or direct current (DC) cardioversion may be required. Long term drug therapy for SVT includes first-line treatment with digoxin, verapamil or propranolol. Ventricular tachycardia is managed acutely with DC cardioversion and intravenous lidocaine (lignocaine). Chronic drug regimens include mexiletine, propranolol or amiodarone.
In children with structural congenital heart disease or myocardial dysfunction, hazards of drug therapy for arrhythmias include depression of cardiac function, proarrhythmia (drug-induced worsening of arrhythmias), and conduction abnormalities. Care must be taken to choose medication regimens which are likely to be effective with minimum risk of potentiating abnormal haemodynamics or conduction.
Similar content being viewed by others
References
Bash SE, Shah JJ, Albers WH, Giess DM. Hypothermia for the treatment of postsurgical greatly accelerated junctional ectopic tachycardia. Journal of the American College of Cardiology 105: 1095–1099, 1987
Belhassen B, Shapira I, Pelleg A, Coperman I, Kauli N, et al. Idiopathic recurrent sustained ventricular tachycardia responsive to verapamil an ECG electrophysiologic entity. American Heart Journal 108(4). 1034–1037, 1984
Benson Jr DW. Transesophageal electrocardiography and cardiac pacing state of the art Circulation 75: III–86–III–90, 1987
Benson DW, Benditi DG, Anderson RW, Dunnigan A, Pritzker MR, et al. Cardiac arrest in young, ostensibly healthy patients: clinical, hemodynamic, and electrophysiologic findings. American Journal of Cardiology 52: 65–69, 1983
Cardiac Arrhythmias Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. New England Journal of Medicine 321(6): 406–412, 1989
Dick M, Scott WA. Amiodarone in pediatric patients. Clinical Progress in Electrophysiology and Pacing 4: 522–527, 1986
Epstein ML, Seibel MA, Hill MR, et al. Pharmacokinetics of chronic oral verapamil therapy in infants. Circulation 74: 77, 1986
Faulds D, Chrisp P, Buckley MM-T. Adenosine. An evaluation of its use in cardiac diagnostic procedures, and in the treatment of paroxysmal supraventricular tachycardia. Drugs 41. 596–624, 1991
Fish FA, Gillette PC, Benson Jr DW, for the Pediatrie Electrophysiology Group Incidence of cardiac arrest and proarrhythmia in young patients receiving flecainide or encainide. Abstract 1539. Circulation 80(4). 11–387, 1989
Frye RL, Collins JJ, DiSanctis RW, Dodge HT, Drehus LS, et al. Guidelines for permanent cardiac pacemaker implantation. Circulation 70 2, 1984
Gallagher JJ, Pntchett ELC, Sealy WC, Rasell J, Wallace AG. The preexcitation syndromes. Progress in Cardiovas pula Diseases 20(4): 285–327, 1978
Garson Jr A, Gillette PC, McVey P, et al. Amiodarone treatment of critical arrhythmias in children and young, adults. Journal of the American College of Cardiology 4: 749–755, 1984
Garson Jr A, McNamara DC. Sudden death in pediatric cardiology population, 1958–1983. relation to prior arrhythmias. Journal of the American College of Cardiology 5(Suppl. 6): 134B–137B, 1985
Garson Jr A, Porter CBJ, Gillette PC, McNamara DG. Induction of ventricular tachycardia during electrophysiologic study after repair of tetralogy of Fallot. Journal of the Amrican College of Cardiology 1(6). 1493–1502, 1983
Gillette PC, Garson Jr A (Eds). Noninvasive diagnostic techniques. In Pediatrie arrhythmia: electrophysiology and pacing, pp. 205–216, WB Saunders CO., Philadelphia 1982
Joint American College of Cardiology/American Heart Association Task Force on Assessment of Cardiovascular Procedures, Subcommittee on Pacemaker Implantation. Guidelines for permanent cardiac pacemaker implantation. Circulation 70: 331–339A, 1984
Ko JK, Deal BH, Strasburger JF, Benson JR DW. Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Journal in press, 1991
Ludomirsky A, Garson Jr A. Supraventricular tachycardia. In Gillette PC & Garson Jr A (Eds) Pediatric arrhythmia: electrophysiology and pacing, pp. 380–426, WB Saunders Co., Philadelphia, 1990
Maragnes P, Former A, Kratz C, Houyel L, Davignon A, et al. Efficacy of sotalol in the pediatric population. Abstract. Circulation 82 [Suppl.] III–224, 1990
Marcus FI. Pharmacokinetics: interactions between digoxin and other drugs. Journal of the American College of Cardiology 5(5): 81A–82A, 1985
Moak JP, Smith RT, Garson Jr A. Mexilitine: an effective antiarrhythmic agent for treatment of ventricular arrhythmias in children with congenital heart disease. Journal of the American College of Cardiology 10: 824–829, 1987
Paul M. Complete transposition of the great arteries. In Adams FH et al. (Eds) Heart disease in infants, children and adolescents, 4th ed., pp. 371–423, Williams and Wilkins, Baltimore, 1989
Perry JC, McQuinn R, Smith RT, et al. Flecainide acetate for resistant arrhythmias in the young: efficacy and pharmacokinetics. Journal of the American College of Cardiology 14: 185–193, 1989
Ruskins JN. The Cardiac Arrhythmias Suppression Trial (CAST). New England Journal of Medicine 321(6): 386–388, 1989
Shen W-K, Holmes DR, Porter CJ, McGoon DC, Filstrup SM. Sudden death after repair of double-outlet right ventricle. Circulation 81: 128–129, 1990
Southall DP, Orrell MJ, Talbot JF, Brinton RJ, Vulliam DG, et al. Study of cardiac arrhythmias and other forms of conduction abnormality in newborn infants. British Medical Journal 2: 597–599, 1977
Strasburger JF, Benson Jr DW. Mechanisms of tachycardia in the premature infant and fetus. Abstract 1875. Circulation 80(4): 11–471, 1989
Strasburger JF, Moak JP, Smith RT, et al. Encainide for refractory supraventricular tachycardia in children. American Journal of Cardiology 58: 49c–54c, 1983
Till J, Shinebourne EA, Rigby ML, Clarke B, Ward DE, et al. Efficacy and safety of adenosine in the treatment of supraventricular tachycardia in infants and children. British Heart Journal 62: 204–211, 1989
Vaughan Williams EM. A classification of antiarrhythmic actions reassessed after a decade of new drugs. Journal of Clinical Pharmacology 24: 129–147, 1984
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Strasburger, J.F. Cardiac Arrhythmias in Childhood. Drugs 42, 974–983 (1991). https://doi.org/10.2165/00003495-199142060-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199142060-00006